No Picture
Trading Ideas

AstraZeneca succeeds in treating lupus in late-stage study

AstraZeneca Plc said on Monday its experimental treatment significantly reduced disease activity in patients with autoimmune disorder lupus, in a late-stage study. The results pit the British drugmaker’s anifrolumab against rival GlaxoSmithKline Plc’s Benlysta – the only new drug approved for lupus in the last 60 years. Benlysta recorded 473 million pounds of global sales in 2018, up 26% from a year earlier. …read more […]

No Picture
Trading Ideas

Twitter takes steps to keep UK election 'healthy and safe'

Twitter said it would make it easier to report misleading information about the voting process in Britain’s Dec. 12 election, less than a month after its global ban on political advertising comes into force. The microblogging site is a vital tool for candidates, political parties and journalists to break news and fuel debate, but it has also been used to spread fake news, such as manipulated video clips, and to abuse and threaten individuals. It said last month it would stop all political advertising, making the British election one of the first major tests for the new policy. …read more […]